Nama Insights

Eli Lilly and Company (LLY)

Healthcare · Drug Manufacturers General · NYSE

S&P 500
Eli Lilly and Company (LLY) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $1.06T, a trailing price-to-earnings ratio of 37.6 and a free-cash-flow yield of 0.6%. Over the most recent reported fiscal year, revenue grew 44.7% and free cash flow per share grew 1348.2%.
Market cap$1.06T
Trailing P/E37.6
FCF yield0.6%
Revenue growth (YoY)+44.7%
EPS growth (YoY)+86.2%
FCF/share growth (YoY)+1348.2%
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers General
Explore live LLY data on Nama Insights →

Recent Congressional trades

Eli Lilly and Company trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Gilbert Cisneros House Buy $50,001 - $100,000 Jul 2, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 May 7, 2026
Byron Donalds House Buy $1,001 - $15,000 May 1, 2026
David J. Taylor House Buy $1,001 - $15,000 Mar 5, 2026
David J. Taylor House Sell $1,001 - $15,000 Feb 17, 2026
Julie Johnson House Sell $1,001 - $15,000 Jan 5, 2026
David J. Taylor House Sell $1,001 - $15,000 Dec 19, 2025
Gilbert Cisneros House Buy $1,001 - $15,000 Dec 12, 2025
Valerie Hoyle House Sell $1,001 - $15,000 Sep 23, 2025
David J. Taylor House Buy $1,001 - $15,000 Aug 19, 2025
Lisa McClain House Sell $1,001 - $15,000 Aug 13, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 11, 2025